Non-ownership Filings
| Total Voting Rights | Oct. 01, 2025 |
| Positive efficacy and tolerance in pediatric trial | Oct. 01, 2025 |
| £1.5 million placing supporting growth of ACCRUFeR | Sep. 15, 2025 |
| Interim results for the six months ended 30 Jun 25 | Sep. 03, 2025 |
| Interim results for the six months ended 30 Jun 25 | Aug. 21, 2025 |
| Result of AGM | May. 22, 2025 |
| Audited results for the year ended 31 Dec 2024 | Apr. 24, 2025 |
Ownership Update Filings
| Grant of Share Options to Chief Executive Officer | Oct. 14, 2025 |
| Grant of Share Options | Feb. 13, 2025 |
| PDMR Transaction Notification | Nov. 27, 2023 |
| Holding(s) in Company | Jul. 24, 2023 |
| Grant of share options to the CEO | Jun. 06, 2023 |
| Holding(s) in Company | Jun. 01, 2023 |
| Holding(s) in Company | Jun. 01, 2023 |